Comparatively, obesity rates in most European countries remain below 25 percent, with some nations, particularly in Southern ...

Obesity extends far beyond carrying extra weight - it represents a chronic condition affecting millions globally. While ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Dr. Cheryl Kendall discusses urgent pediatric health concerns, offering solutions for childhood obesity and digital addiction ...

Obesity surgery (also known as bariatric and metabolic surgery) is one of the most common reasons people engage in so-called ...

Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...

Eli Lilly wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in ...

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...

In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...